Cost of Revenue

$576.50M

Quarterly · Period ending: Jun 30, 2026 · USD

REGN Cost of Revenue

Latest reported$576.50Mperiod endingJun 30, 2026

REGN Quarterly Cost of Revenue ($0.00 → $576.50M)

Quarterly cost of revenue

High-resolution chart · PNG

REGN cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Cost of Revenue — Quarterly (USD)
Period ending	Cost of Revenue (USD)
Jun 30, 2026	576,500,000
Mar 31, 2026	669,400,000
Dec 31, 2025	584,600,000
Sep 30, 2025	521,600,000
Jun 30, 2025	530,200,000
Mar 31, 2025	464,300,000
Dec 31, 2024	565,400,000
Sep 30, 2024	491,100,000
Jun 30, 2024	480,200,000
Mar 31, 2024	433,800,000
Dec 31, 2023	629,100,000
Sep 30, 2023	541,800,000
Jun 30, 2023	508,000,000
Mar 31, 2023	557,000,000
Dec 31, 2022	507,000,000
Sep 30, 2022	410,400,000
Jun 30, 2022	371,500,000
Mar 31, 2022	479,200,000
Dec 31, 2021	1,057,099,999
Sep 30, 2021	526,400,000
Jun 30, 2021	764,800,000
Mar 31, 2021	375,400,000
Dec 31, 2020	414,800,000
Sep 30, 2020	333,300,000
Jun 30, 2020	334,300,000
Mar 31, 2020	273,400,000
Dec 31, 2019	276,000,000
Sep 30, 2019	278,400,000
Jun 30, 2019	197,900,000
Mar 31, 2019	223,100,000
Dec 31, 2018	159,959,000
Sep 30, 2018	145,810,000
Jun 30, 2018	125,303,000
Mar 31, 2018	151,256,000
Dec 31, 2017	140,247,000
Sep 30, 2017	141,951,000
Jun 30, 2017	138,047,000
Mar 31, 2017	122,283,000
Dec 31, 2016	103,581,000
Sep 30, 2016	72,067,000
Jun 30, 2016	69,033,000
Mar 31, 2016	111,752,000
Dec 31, 2015	110,831,000
Sep 30, 2015	109,083,000
Jun 30, 2015	88,840,000
Mar 31, 2015	83,955,000
Dec 31, 2014	59,474,000
Sep 30, 2014	55,593,000
Jun 30, 2014	46,379,000
Mar 31, 2014	43,572,000
Dec 31, 2013	48,114,000
Sep 30, 2013	38,573,000
Jun 30, 2013	39,613,000
Mar 31, 2013	29,055,000
Dec 31, 2012	30,169,000
Sep 30, 2012	20,145,000
Jun 30, 2012	21,843,000
Mar 31, 2012	12,298,000
Dec 31, 2011	2,989,000
Sep 30, 2011	450,000
Jun 30, 2011	395,000
Mar 31, 2011	382,000
Dec 31, 2010	599,000
Sep 30, 2010	372,000
Jun 30, 2010	405,000
Mar 31, 2010	717,000
Dec 31, 2009	387,000
Sep 30, 2009	472,000
Jun 30, 2009	435,000
Mar 31, 2009	392,000
Dec 31, 2008	631,000
Sep 30, 2008	292,000
Jun 30, 2008	6,900
Mar 31, 2008	0
Dec 31, 2007	0
Sep 30, 2007	0
Jun 30, 2007	0
Mar 31, 2007	0
Dec 31, 2006	430,000
Sep 30, 2006	3,054,000
Jun 30, 2006	2,810,000
Mar 31, 2006	1,852,000
Dec 31, 2005	2,145,000
Sep 30, 2005	3,246,000
Jun 30, 2005	1,675,000
Mar 31, 2005	2,491,000
Dec 31, 2004	3,474,000
Sep 30, 2004	8,986,000
Jun 30, 2004	529,000
Mar 31, 2004	2,225,000
Dec 31, 2003	907,000
Sep 30, 2003	4,844,000
Jun 30, 2003	259,000
Mar 31, 2003	666,000
Dec 31, 2002	1,726,000
Sep 30, 2002	1,637,000
Jun 30, 2002	1,861,000
Mar 31, 2002	1,259,000
Dec 31, 2001	1,162,000
Sep 30, 2001	1,274,000